Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Coronaviruses
  4. Fast Track Articles
  5. Fast Track Article
image of The Impact of Diabetes-related Factors on the Severity and Outcome of COVID-19 Infection in Hospitalized Patients: A Descriptive-analytical Study

Abstract

Introduction

The COVID-19 pandemic is having a devastating impact on public health, with a higher risk of severe illness and mortality in vulnerable groups. Individuals with a history of diabetes are more prone to severe COVID-19. A collection of hyperglycemia, inflammation, and impaired immunity in diabetes, especially in poor glycemic control, notably increases the risk of COVID-19 severity. Hyperglycemia can trigger the release of inflammatory cytokines, highlighting the intricate relationship between glucose metabolism and inflammation, and contributing to cytokine storms that worsen COVID-19 severity. Understanding this relationship enables healthcare providers to develop personalized care strategies for managing blood glucose in diabetic patients, thereby reducing the risk of severe COVID-19 outcomes. This study aims to identify the factors that contribute to the severe outcomes of COVID-19 in patients with diabetes, to better understand and manage this critical combination.

Methods

A total of 411 patients with COVID-19 infection referred to the Teaching Hospital of Mazandaran University of Medical Sciences, Sari, were included in this study. The COVID-19 severity was evaluated according to the World Health Organization (WHO) guidelines. All information including demographic, clinical, and laboratory data as well as severity and outcome of the disease were compared between diabetic and non-diabetic patients.

Results

The diabetic patients had higher blood glucose (210.3 ±114.9 mg/dl) compared to non-diabetics (118.74 ±3.8 mg/dl) upon admission (=0.0001). Diabetics also experienced more severe COVID-19 infection (=0.048). Patients with severe COVID-19 had significantly higher blood glucose (168.5 ±12.8 mg/dl) than those with non-severe infection (136.6± 6.3 mg/dl) (=0.013). Diabetics had higher erythrocyte sedimentation rates (ESR) compared to non-diabetics (52.25±2.4 vs. 43.81±1.8 mm/h, =0.006). Diabetic patients taking ACEIs/ARBs had more severe COVID-19 infection (=0.031).

Conclusion

The study discovered a positive relationship between hyperglycemia and COVID-19 severity, as well as a higher risk of severe COVID-19 among patients taking ACEIs or ARBs.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/012666797533458424121116012226
2024-12-16
2025-01-31

  • From This Site

    /content/journals/covid/10.2174/012666797533458424121116012226
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. COVID-19: WHO Coronavirus Disease (COVID-19) Dashboard. 2024 Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  2. Al-Sabah S Al-Haddad M Al-Youha S Jamal M Almazeedi S. COVID-19: Impact of obesity and diabetes on disease severity. Clin Obes. 2020 10 6 e12414
    [Google Scholar]
  3. Jordan R.E. Adab P. Cheng K.K. Covid-19: risk factors for severe disease and death. BMJ 2020 368 m1198 10.1136/bmj.m1198 32217618
    [Google Scholar]
  4. Sarwar N. Gao P. Seshasai S.R. Gobin R. Kaptoge S. Di Angelantonio E. Ingelsson E. Lawlor D.A. Selvin E. Stampfer M. Stehouwer C.D. Lewington S. Pennells L. Thompson A. Sattar N. White I.R. Ray K.K. Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010 375 9733 2215 2222 10.1016/S0140‑6736(10)60484‑9 20609967
    [Google Scholar]
  5. Hassanein M. Radhakrishnan Y. Sedor J. Vachharajani T. Vachharajani V.T. Augustine J. Demirjian S. Thomas G. COVID-19 and the kidney. Cleve. Clin. J. Med. 2020 87 10 619 631 10.3949/ccjm.87a.20072 33004323
    [Google Scholar]
  6. Alrashed A.A. Khan T.M. Alhusseini N.K. Asdaq S.M.B. Enani M. Alosaimi B. Alkhani N.M. Mohzari Y. Alghalbi M.M. Alfahad W. Alanazi M.A. Albujaidya A.S. Ben-Akresh A. Almutairi M. Abraham I. Alamer A. Severity of COVID-19 infection in ACEI/ARB users in specialty hospitals: A retrospective cohort study. J. Infect. Public Health 2021 14 6 726 733 10.1016/j.jiph.2021.03.004 34020213
    [Google Scholar]
  7. Mohamed-Jawad N.K. COVID-19 and the risk of diabetes: A systematic review article. Asia Pac. J. Med. Toxicol. 2023 12 2
    [Google Scholar]
  8. Magdy Beshbishy A. Oti V.B. Hussein D.E. Rehan I.F. Adeyemi O.S. Rivero-Perez N. Zaragoza-Bastida A. Shah M.A. Abouelezz K. Hetta H.F. Cruz-Martins N. Batiha G.E.S. Factors behind the higher COVID-19 risk in diabetes: a critical review. Front. Public Health 2021 9 591982 10.3389/fpubh.2021.591982 34307267
    [Google Scholar]
  9. Heshmati H.M. Interactions between COVID-19 infection and diabetes. Front. Endocrinol. (Lausanne) 2024 14 1306290 10.3389/fendo.2023.1306290 38292772
    [Google Scholar]
  10. Khunti K. Aroda V.R. Aschner P. Chan J.C.N. Del Prato S. Hambling C.E. Harris S. Lamptey R. McKee M. Tandon N. Valabhji J. Seidu S. The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. Lancet Diabetes Endocrinol. 2022 10 12 890 900 36356612
    [Google Scholar]
  11. Bode B. Garrett V. Messler J. McFarland R. Crowe J. Booth R. Klonoff D.C. Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States. J. Diabetes Sci. Technol. 2020 14 4 813 821 32389027
    [Google Scholar]
  12. Xhu L. She Z. Cheng X. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020 31 6 1068 1077.e3 10.1016/j.cmet.2020.04.021 32369736
    [Google Scholar]
  13. Xiao F. Zhou Y.C. Zhang M.B. Chen D. Peng S.L. Tang H.N. Li L. Tang C.Y. Liu J.Y. Li B. Zhou H.D. Hyperglycemia and blood glucose deterioration are risk factors for severe COVID-19 with diabetes: A two-center cohort study. J. Med. Virol. 2022 94 5 1967 1975 34967028
    [Google Scholar]
  14. Zahid S. Bodicherla K.P. Eskander N. Patel R.S. Attention-deficit/hyperactivity disorder and suicidal risk in major depression: analysis of 141,530 adolescent hospitalizations. Cureus 2020 12 5 e7949 32509475
    [Google Scholar]
  15. Tay M.Z. Poh C.M. Rénia L. MacAry P.A. Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 2020 20 6 363 374 10.1038/s41577‑020‑0311‑8
    [Google Scholar]
  16. Organization W.H. IMAI district clinician manual: hospital care for adolescents and adults: guidelines for the management of common illnesses with limited resources. 2011
    [Google Scholar]
  17. Ranieri V.M. Rubenfeld G.D. Thompson B.T. Ferguson N.D. Caldwell E. Fan E. Camporota L. Slutsky A.S. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012 307 23 2526 2533 22797452
    [Google Scholar]
  18. Klekotka R.B. Mizgała E. Król W. The etiology of lower respiratory tract infections in people with diabetes. Pneumonol. Alergol. Pol. 2015 83 5 401 408 26379004
    [Google Scholar]
  19. Elamari S. Motaib I. Zbiri S. Elaidaoui K. Chadli A. Elkettani C. Characteristics and outcomes of diabetic patients infected by the SARS-CoV-2. Pan Afr. Med. J. 2020 37 32 10.11604/pamj.2020.37.32.25192 33209159
    [Google Scholar]
  20. Jayaswal S.K. Singh S. Malik P.S. Venigalla S.K. Gupta P. Samaga S.N. Hota R.N. Bhatia S.S. Gupta I. Detrimental effect of diabetes and hypertension on the severity and mortality of COVID-19 infection: A multi-center case-control study from India. Diabetes Metab. Syndr. 2021 15 5 102248 10.1016/j.dsx.2021.102248 34412000
    [Google Scholar]
  21. Guan W-j. Ni Z-y. Hu Y. Liang W-h. Ou C-q. He J-x. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv 2020 2020 10.1101/2020.02.06.20020974
    [Google Scholar]
  22. Zhang N. Wang C. Zhu F. Mao H. Bai P. Chen L.L. Zeng T. Peng M.M. Qiu K.L. Wang Y. Yu M. Xu S. Zhao J. Li N. Zhou M. Risk factors for poor outcomes of diabetes patients with COVID-19: a single-center, retrospective study in early outbreak in China. Front. Endocrinol. (Lausanne) 2020 11 571037 10.3389/fendo.2020.571037 33071977
    [Google Scholar]
  23. Zhang Y. Li H. Zhang J. Cao Y. Zhao X. Yu N. Gao Y. Ma J. Zhang H. Zhang J. Guo X. Liu X. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in Wuhan. Diabetes Obes. Metab. 2020 22 8 1443 1454 10.1111/dom.14086 32406594
    [Google Scholar]
  24. Chen J. Wu C. Wang X. Yu J. Sun Z. The impact of COVID-19 on blood glucose: A systematic review and meta-analysis. Front. Endocrinol. (Lausanne) 2020 11 574541 10.3389/fendo.2020.574541 33123093
    [Google Scholar]
  25. Ding Y. He L. Zhang Q. Huang Z. Che X. Hou J. Wang H. Shen H. Qiu L. Li Z. Geng J. Cai J. Han H. Li X. Kang W. Weng D. Liang P. Jiang S. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J. Pathol. 2004 203 2 622 630 10.1002/path.1560 15141376
    [Google Scholar]
  26. Yang J.K. Lin S.S. Ji X.J. Guo L.M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010 47 3 193 199 10.1007/s00592‑009‑0109‑4 19333547
    [Google Scholar]
  27. McGuinness O.P. Defective glucose homeostasis during infection. Annu. Rev. Nutr. 2005 25 1 9 35 10.1146/annurev.nutr.24.012003.132159 16011457
    [Google Scholar]
  28. Samimagham H.R. Hassani Azad M. Arabi M. Hooshyar D. Sheikhtaheri A. Khorrami F. Hosseini Teshnizi S. Kazemi Jahromi M. COVID-19 severity and comorbidities in diabetic patients. Disease and Diagnosis 2021 10 3 91 98 10.34172/ddj.2021.18
    [Google Scholar]
  29. Kumar B. Mittal M. Gopalakrishnan M. Garg M.K. Misra S. Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital. Endocr. Connect. 2021 10 6 589 598 10.1530/EC‑21‑0086 33971617
    [Google Scholar]
  30. Alessi J. de Oliveira G.B. Schaan B.D. Telo G.H. Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes. Diabetol. Metab. Syndr. 2020 12 1 80 10.1186/s13098‑020‑00583‑7 32922517
    [Google Scholar]
  31. Spick M. Campbell A. Baricevic-Jones I. von Gerichten J. Lewis H.M. Frampas C.F. Longman K. Stewart A. Dunn-Walters D. Skene D.J. Geifman N. Whetton A.D. Bailey M.J. Multi-omics reveals mechanisms of partial modulation of COVID-19 dysregulation by glucocorticoid treatment. Int. J. Mol. Sci. 2022 23 20 12079 10.3390/ijms232012079 36292938
    [Google Scholar]
  32. Gupta R. Hussain A. Misra A. Diabetes and COVID-19: evidence, current status and unanswered research questions. Eur. J. Clin. Nutr. 2020 74 6 864 870 10.1038/s41430‑020‑0652‑1 32404898
    [Google Scholar]
  33. Singh R Rathore SS Khan H Bhurwal A Sheraton M Ghosh P Mortality and severity in COVID-19 Patients on ACEIs & ARBs-A meta-regression analysis. 2021
    [Google Scholar]
  34. Nahum L.H. The renin angiotensin-aldosterone system (RAAS) in normal man. Conn. Med. 1965 29 10 710 711 4284109
    [Google Scholar]
  35. Rico-Mesa J.S. White A. Anderson A.S. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB. Curr. Cardiol. Rep. 2020 22 5 31 10.1007/s11886‑020‑01291‑4 32291526
    [Google Scholar]
  36. Fang L. Karakiulakis G. Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020 8 4 e21 10.1016/S2213‑2600(20)30116‑8 32171062
    [Google Scholar]
  37. Azami P. Vafa R.G. Heydarzadeh R. Sadeghi M. Amiri F. Azadian A. Khademolhosseini A. Yousefi M. Montaseri M. Hosseini N. Hosseini S.A. Kojuri J. Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study. BMC Cardiovasc. Disord. 2024 24 1 240 10.1186/s12872‑024‑03916‑w 38714940
    [Google Scholar]
  38. Li G. Deng Q. Feng J. Li F. Xiong N. He Q. Clinical characteristics of diabetic patients with COVID-19. J. Diabetes Res. 2020 2020 1652403 10.1155/2020/1652403 32851093
    [Google Scholar]
  39. Hafeez M. Samin K.A. Din H.U. Ullah S. Sheikh M.U. Hassan T. Association of mortality between diabetic and non diabetic patients with Covid 19. Pak. J. Med. Health Sci. 2022 16 2 1212 1214 10.53350/pjmhs221621212
    [Google Scholar]
  40. Palaiodimos L. Chamorro-Pareja N. Karamanis D. Li W. Zavras P.D. Chang K.M. Mathias P. Kokkinidis D.G. Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients. Hormones (Athens) 2021 20 2 305 314 10.1007/s42000‑020‑00246‑2 33123973
    [Google Scholar]
  41. Kang Y.M. Kim Y.J. Park J.Y. Lee W.J. Jung C.H. Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013. Cardiovasc. Diabetol. 2016 15 1 131 10.1186/s12933‑016‑0451‑0 27618811
    [Google Scholar]
  42. Vasan S.K. Pittard A.E.I. Abraham J. Samuel P. Seshadri M.S. Thomas N. Cause‐specific mortality in diabetes: Retrospective hospital based data from south India. J. Diabetes 2012 4 1 47 54 10.1111/j.1753‑0407.2011.00165.x 22018101
    [Google Scholar]
/content/journals/covid/10.2174/012666797533458424121116012226
Loading
The Impact of Diabetes-related Factors on the Severity and Outcome of COVID-19 Infection in Hospitalized Patients: A Descriptive-analytical Study
Bentham Science Publishers ; https://doi.org/10.2174/012666797533458424121116012226
/content/journals/covid/10.2174/012666797533458424121116012226
/content/journals/covid/10.2174/012666797533458424121116012226
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: severity ; ACEIs/ARBs ; inflammatory markers ; COVID-19 ; hyperglycemia ; outcome
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test